Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon J Freeman

Showing results (11-20 of 348) with videos related to

Pageof 35
Sort By:
Nature Reviews. Immunology|January 23, 2020
The importance of exosomal PDL1 in tumour immune evasionDhouha Daassi, Kathleen M Mahoney, Gordon J Freeman
Trends in Molecular Medicine|May 14, 2016
Learning from PD-1 Resistance: New Combination StrategiesXia Bu, Kathleen M Mahoney, Gordon J Freeman
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2014
Comment on "Tim-3 directly enhances CD8 T cell responses to acute Listeria monocytogenes infection"Vijay K Kuchroo, Ana C Anderson, Gordon J Freeman
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|June 21, 2023
Novel Antimurine Thyroid-Stimulating Hormone Receptor Monoclonal AntibodiesAlyssa N Klee, James A Torchia, Gordon J Freeman
Clinical Therapeutics|April 1, 2015
The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in MelanomaKathleen M Mahoney, Gordon J Freeman, David F McDermott
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissuesMary E Keir, Gordon J Freeman, Arlene H Sharpe
Nature Reviews. Drug Discovery|August 1, 2015
Combination cancer immunotherapy and new immunomodulatory targetsKathleen M Mahoney, Paul D Rennert, Gordon J Freeman
Nature Medicine|August 2, 2002
Protect the killer: CTLs need defenses against the tumorGordon J Freeman, Arlene H Sharpe, Vijay K Kuchroo
Annual Review of Immunology|March 18, 2005
The B7 family revisitedRebecca J Greenwald, Gordon J Freeman, Arlene H Sharpe
Biotechniques|October 3, 2007
In-fusion assembly: seamless engineering of multidomain fusion proteins, modular vectors, and mutationsBaogong Zhu, Guifang Cai, Emily O Hall, et al.
Pageof 35

Showing results (11-20 of 348) with videos related to

Sort By:
Pageof 35
Nature Reviews. Immunology|January 23, 2020
The importance of exosomal PDL1 in tumour immune evasionDhouha Daassi, Kathleen M Mahoney, Gordon J Freeman
Trends in Molecular Medicine|May 14, 2016
Learning from PD-1 Resistance: New Combination StrategiesXia Bu, Kathleen M Mahoney, Gordon J Freeman
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2014
Comment on "Tim-3 directly enhances CD8 T cell responses to acute Listeria monocytogenes infection"Vijay K Kuchroo, Ana C Anderson, Gordon J Freeman
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|June 21, 2023
Novel Antimurine Thyroid-Stimulating Hormone Receptor Monoclonal AntibodiesAlyssa N Klee, James A Torchia, Gordon J Freeman
Clinical Therapeutics|April 1, 2015
The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in MelanomaKathleen M Mahoney, Gordon J Freeman, David F McDermott
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissuesMary E Keir, Gordon J Freeman, Arlene H Sharpe
Nature Reviews. Drug Discovery|August 1, 2015
Combination cancer immunotherapy and new immunomodulatory targetsKathleen M Mahoney, Paul D Rennert, Gordon J Freeman
Nature Medicine|August 2, 2002
Protect the killer: CTLs need defenses against the tumorGordon J Freeman, Arlene H Sharpe, Vijay K Kuchroo
Annual Review of Immunology|March 18, 2005
The B7 family revisitedRebecca J Greenwald, Gordon J Freeman, Arlene H Sharpe
Biotechniques|October 3, 2007
In-fusion assembly: seamless engineering of multidomain fusion proteins, modular vectors, and mutationsBaogong Zhu, Guifang Cai, Emily O Hall, et al.
Pageof 35